Hepatitis B infection and changes in interferon-α and -γ production in patients with systemic lupus erythematosus in Taiwan

Journal of Gastroenterology and Hepatology (Australia)

Volumn 12, Issue 4, 1997, Pages 272-276

  Lu, Ching Liang ^a   Tsai, Shih Tzu ^a   Chan, Cho Yu ^a   Hwang, Shinn Jang ^a   Tsai, Chang Youh ^a   Wu, Jaw Ching ^a   Lu, Ruey Hwa ^a   Lin, Bao Cherng ^a   Lee, Shou Dong ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

hepatitis B surface antigen; interferons; systemic lupus erythematosus

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION RISK; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TAIWAN;

EID: 0030971012     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1997.tb00420.x     Document Type: Article

References (24)

1. Alarcön-Segovia D, Fishbein E, Diaz-Jouanen E. Presence of hepatitis-associated antigen in systemic lupus erythematosus. Clin. Exp. Immunol. 1972; 12: 9-19.
2. Ziegenfuss JF, Byrne EB, Stoloff IL, Burka ER. Australia antigen in systemic lupus erythematosus. Lancet 1972; i: 800.
3. Permin H, Aldershville J, Nielsen JO. Hepatitis B virus infection in patients with rheumatic diseases. Ann. Rheum. Dis. 1982; 41: 479-82.
4. Panush RS, Alpert E, Schur PH. Absence of Australian antigen and antibody in patients with rheumatic diseases. Arthritis Rheum. 1971; 14: 782-3.
5. Shorey J, Cheatum DE, Combes B, Ziff M. Hepatitis B antigen and antibody in patients with systemic lupus erythematosus. Arthritis Rheum. 1974; 17: 583-9.
6. Bonafide RP, van Staden M, Klemp P. Hepatitis B virus infection and liver function in patients with systemic lupus erythematosus. J. Rheumatol. 1986; 13: 1050-2.
7. Chng HH, Fock KM, Chew CN et al. Hepatitis B virus infection in patients with systemic lupus erythematosus. Singapore Med. J. 1993; 34: 325-6.
8. Sung JL, Chen DS, Lai MY et al Epidemiological study on hepatitis B virus infection in Taiwan. Chin. J. Gastroenterol. 1984; 1: 1-9.
9. Peters M. Mechanisms of action of interferons. Semin. Liver Dis. 1989; 9: 235-9.
10. Zachoval R, Abb J, Zachoval V et al. Interferon alpha in hepatitis type B and non-A, non-B. J. Hepatol. 1988; 6: 364-8.
11. Ikeda T, Lever AML, Thomas HC. Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult life. Hepatology 1986; 6: 962-5.
12. Abb J, Zachoval R, Eisenburg J, Pape GR, Zachoval V, Deinhardt F. Production of interferon alpha and interferon gamma by peripheral blood leukocytes from patients with chronic hepatitis B virus infection. J. Med. Virol. 1985; 16: 171-6.
13. Alarcôn-Segovia D, Ruiz-Gômez J, Fishbein E, Bustamante ME. Interferon production by lymphocytes from patients with systemic lupus erythematosus. Arthritis Rheum. 1974; 17: 590-2.
14. Neighbour PA, Grayzel AI. Interferon production in vitro by leukocytes from patients with systemic lupus erythematosus and rheumatoid arthritis. Clin. Exp. Immnol. 1981; 45: 576-82.
15. Tsokos GC, Boumpas DT, Smith PL, Djeu JY, Balow JE, Rook AH. Deficient γ-interferon production in patients with systemic lupus erythematosus. Arthritis Rheum. 1986; 29: 1210-15.
16. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982; 25: 1271-7.
17. Tsai CY, Wu TH, Sun KH, Lin WM, Yu CL. Increased excretion of soluble interleukin 2 receptors and free light chain immunoglobulins in the urine of patients with active lupus nephritis. Ann. Rheum. Dis. 1992; 51: 168-72.
18. Chan CY, Lee SD, Huang YS et al. Primary biliary cirrhosis in Taiwan. J. Gastroenterol. Hepatol. 1990; 5: 560-5.
19. Chien RN, Sheen IS, Liaw YF. Low prevalence of HBV and HCV infection in patients with primary biliary cirrhosis in Taiwan: A case control study. J. Gastroenterol. Hepatol. 1993; 8: 574-6.
20. Greenwood BM. Autoimmune disease and parasitic infections in Nigerians. Lancet 1968; ii: 380-2.
21. Butcher GA, Clark IA. SLE and malaria: Another look at an old idea. Parasitai. Today 1990; 6: 259-61.
22. Greenwood BM, Herrick EM, Voiler A. Suppression of autoimmune disease in NZB and (NZB x NZW)F1 hybrid mice by infection with malaria. Nature 1970;-226: 266-7.
23. Baig MM, Shere SJ. Prevalence of autoantibodies in Saudi population. J. Med. 1989; 20: 286-90.
24. Forslid J, Heigl Z, Jonsson J, Scheynius A. The prevalence of autoantibodies in healthy young persons and adults, comparing rat liver tissue sections with HEp-2 cells as antigen substrate. Clin. Exp. Rheumatol. 1994; 12: 1137-41.